Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs WANBURY - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA WANBURY BLISS GVS PHARMA/
WANBURY
 
P/E (TTM) x 13.1 20.5 64.1% View Chart
P/BV x 1.3 - - View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   WANBURY
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
WANBURY
Mar-23
BLISS GVS PHARMA/
WANBURY
5-Yr Chart
Click to enlarge
High Rs9190 102.1%   
Low Rs6733 203.6%   
Sales per share (Unadj.) Rs72.2152.8 47.2%  
Earnings per share (Unadj.) Rs7.4-3.2 -231.8%  
Cash flow per share (Unadj.) Rs9.20.6 1,506.5%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs84.0-10.5 -797.8%  
Shares outstanding (eoy) m104.1532.71 318.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.10.4 274.1%   
Avg P/E ratio x10.8-19.3 -55.9%  
P/CF ratio (eoy) x8.7100.8 8.6%  
Price / Book Value ratio x0.9-5.8 -16.2%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m8,2622,004 412.3%   
No. of employees `000NANA-   
Total wages/salary Rs m862810 106.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,5164,996 150.4%  
Other income Rs m17810 1,764.5%   
Total revenues Rs m7,6945,007 153.7%   
Gross profit Rs m1,173225 521.8%  
Depreciation Rs m187124 150.8%   
Interest Rs m104214 48.4%   
Profit before tax Rs m1,061-103 -1,031.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2931 26,914.7%   
Profit after tax Rs m767-104 -738.1%  
Gross profit margin %15.64.5 346.9%  
Effective tax rate %27.7-1.1 -2,610.2%   
Net profit margin %10.2-2.1 -490.7%  
BALANCE SHEET DATA
Current assets Rs m6,9741,222 570.9%   
Current liabilities Rs m1,9333,204 60.3%   
Net working cap to sales %67.1-39.7 -169.1%  
Current ratio x3.60.4 946.3%  
Inventory Days Days394 956.5%  
Debtors Days Days1,871497 376.7%  
Net fixed assets Rs m4,5621,742 261.8%   
Share capital Rs m104327 31.8%   
"Free" reserves Rs m8,646-672 -1,287.5%   
Net worth Rs m8,750-344 -2,540.1%   
Long term debt Rs m4070-   
Total assets Rs m11,5352,984 386.6%  
Interest coverage x11.20.5 2,164.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.7 38.9%   
Return on assets %7.63.7 204.9%  
Return on equity %8.830.2 29.1%  
Return on capital %12.7-32.2 -39.4%  
Exports to sales %058.0 0.0%   
Imports to sales %020.5 0.0%   
Exports (fob) Rs mNA2,899 0.0%   
Imports (cif) Rs mNA1,024 0.0%   
Fx inflow Rs m5,6182,997 187.5%   
Fx outflow Rs m1,2251,072 114.3%   
Net fx Rs m4,3941,925 228.2%   
CASH FLOW
From Operations Rs m343198 173.3%  
From Investments Rs m-78-88 87.7%  
From Financial Activity Rs m-249-320 78.0%  
Net Cashflow Rs m30-210 -14.4%  

Share Holding

Indian Promoters % 35.0 30.6 114.4%  
Foreign collaborators % 0.0 9.2 -  
Indian inst/Mut Fund % 22.0 0.0 -  
FIIs % 15.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 60.2 108.0%  
Shareholders   40,758 11,616 350.9%  
Pledged promoter(s) holding % 0.0 99.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs WANBURY

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs WANBURY Share Price Performance

Period BLISS GVS PHARMA WANBURY S&P BSE HEALTHCARE
1-Day -1.31% 3.07% 1.18%
1-Month -9.12% -12.77% -0.75%
1-Year 58.26% 285.24% 61.82%
3-Year CAGR 3.89% 20.19% 18.16%
5-Year CAGR -8.75% 44.69% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the WANBURY share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of WANBURY the stake stands at 39.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of WANBURY.

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

WANBURY paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of WANBURY.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.